methylnaltrexone FDA Link

RN given refers to parent cpd(5alpha)-isomer

Also Known As:

(5alpha)- 17- (cyclopropylmethyl)- 3,14- dihydroxy- 17- methyl- 4,5- epoxymorphinan- 17- ium- 6- one; 17- (cyclopropylmethyl)- 4,5- epoxy- 3,14- dihydroxymorphinanium- 6- one; MRZ 2663BR; MRZ-2663; N-methylnaltrexone bromide; Relistor; methyl-naltrexone hydrobromide; methylnaltrexone bromide; morphinan-17-ium-6-one, 17- (cyclopropylmethyl)- 4,5- epoxy- 3,14- dihydroxy- 17- methyl- , (5alpha)-; morphinan-17-ium-6-one, 17- (cyclopropylmethyl)- 4,5- epoxy- 3,14- dihydroxy- 17- methyl- , bromide, (5alpha,17R)-; morphinanium, 17- (cyclopropylmethyl)- 4,5- epoxy- 3,14- dihydroxy- 17- methyl- 6- oxo- , (5alpha)-; naltrexone MB; naltrexone methobromide; naltrexone methylbromide; naltrexonium methiodide; quaternary ammonium naltrexone

Pharmalogical Action Categories:

D009292 - Narcotic Antagonists

Inorganic Chemicals: 9
- Nitrogen Compounds: 67
  - Ammonium Compounds: 1606
    - Quaternary Ammonium Compounds: 136
      - methylnaltrexone: 229
Organic Chemicals: 133
- Amines: 4871
  - Quaternary Ammonium Compounds: 136
    - methylnaltrexone: 229
- Onium Compounds
  - Quaternary Ammonium Compounds: 136
    - methylnaltrexone: 229
Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Opiate Alkaloids: 5944
    - Morphinans: 33
      - Naloxone: 5958
        Naltrexone: 2720
        methylnaltrexone: 229
- Bridged-Ring Heterocyclic Compounds
  - Morphinans: 33
    - Naloxone: 5958
      - Naltrexone: 2720
        methylnaltrexone: 229
- Fused-Ring Heterocyclic Compounds
  - 4 or More Rings Heterocyclic Compounds
    - Morphinans: 33
      - Naloxone: 5958
        Naltrexone: 2720
        methylnaltrexone: 229
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Phenanthrenes: 27
    - Morphinans: 33
      - Naloxone: 5958
        Naltrexone: 2720
        methylnaltrexone: 229

Amelia Rodrigues Selected Research

Amelia Rodrigues Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure